RxDoctor Payments Data

Kenneth Odinet, MD

Plastic Surgery · Lafayette, LANPI 1942282389

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 60.2% of it on its own, with 10 other manufacturers making up the rest. That places this record below the midpoint for plastic surgery clinicians in LA, where the typical reported total is $2,768.

$1,780in general payments, 2019–2025

Across 91 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Galderma Laboratories, L.p.$252
  • Musculoskeletal Transplant Foundation Inc.$131
  • Smith+Nephew$85
  • Tepha Inc$58
  • Johnson & Johnson$54
  • plus $128 from 5 others
$360in research payments, 2019–2025

Across 2 payments — averaging $180.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$360

What the payments were for

  • Speaking & faculty fees$1508%
  • Food & beverage$1,63092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,780 in reported general payments places this provider in the 35th percentile of 49 plastic surgery providers in Louisiana.

See all plastic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$15,940
Medicare patients
56
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$128
Cephalexin23$102

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →